Cytokines in multiple sclerosis: Pro-inflammation or pro-remyelination?

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 169-173

  Sharief, M K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokines; Demyelination; Oligodendrocytes; Remyelination

Indexed keywords

CYTOKINE; MYELIN;

ARTICLE; CELL INFILTRATION; DEMYELINATION; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; REMYELINIZATION;

EID: 0031664039     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400315     Document Type: Article

References (35)

1. Freedman MS, D'Souza S, Antel JP. (1997) Gamma delta T-cell-human glial cell interactions I. In vitro induction of gammadelta T-cell expansion by human glial cells. J Neuroimmunol 74: 135 - 142.
2. Liuzzi GM, Riccio P, Dal Canto MC. (1995) Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice. J Neuroimmunol 62: 91 - 102.
3. Antel JP et al. (1994) Oligodendrocyte lysis by CD4+ T cells independent of tumor necrosis factor. Ann Neurology 35: 341 - 348.
4. Selmaj K, Raine CS, Cross AH. (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30: 694 - 700.
5. Selmaj K, Raine CS, Cannella B, Brosnan C. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis. J Clin Invest 87: 949 - 954.
6. Mitrovic B et al. (1995) Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neurosci 65: 531 - 539.
7. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ. (1993) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neuroscience 13: 1441 - 1453.
8. Husain J, Juurlink BH. Oligodendroglial precursor cell susceptibility to hypoxia is related to poor ability to cope with reactive oxygen species. Brain Res 698: 86 - 94.
9. Raine CS. (1997) The Norton Lecture: a review of the oligodendrocyte in multiple sclerosis lesion. J Neuroimmunol 77: 135 - 152.
10. Raine CS, Wu E. (1993) Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neural 52: 199 - 204.
11. Knapp PE. (1997) Injury stimulates outgrowth and motility of oligodendrocytes grown in vitro. Exp Cell Res 234: 7 - 17.
12. Loughlin AJ et al. (1997) Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages. J Neurosci Res 47: 384 - 392.
13. Hofman FM, Hinton DR, Johnson K, Merrill JE. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607 - 612.
14. Sharief MK, Hentges R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Eng J Med 325: 467 - 472.
15. Tsukada N et al. (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci 102: 230 - 234.
16. Riechman P et al. (1995) TNF-α messenger RNA expression in patients with relapsing remitting multiple sclerosis is associated with disease activity. Ann Neurol 37: 82 - 88.
17. Hartung HP et al. (1995) Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 45(suppl 6); S22-S32.
18. Wong GH. (1995) Protective roles of cytokines agianst radiation: induction of mitochondial Mn SOD. Biochem Biophys Acta 1271: 205 - 209.
19. Bruce AJ et al. (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury to mice lacking TNF receptor. Nature Med 2: 788 - 794.
20. Cheng B, Mattson MP. (1994) Tumour necrosis factor protects neurons against excitotoxic/metabolic insults and promotes maintainance of calcium homeostasis. Neuron 12: 139 - 153.
21. Rothwell NJ, Luheshi GN. (1996) Brain TNF: damage limitation or damaged reputation? Nature Med 2: 746 - 747.
22. Vandanabeele P, DePercq W, Beyaert R, Fiers W. (1995) Two tumor necrosis factor receptors: structure and functions. Trends Biochem Sci 5: 392 - 399.
23. Rothwell N, Allan S, Toulmond S. (1997) The role of interleukin 1 in acute neurodegeneration and stroke: pathophysioiogical and therapeutic implications. J Clin Invest 100: 2648 - 2652.
24. Brosnan CF, Cannell B, Battistini L, Raine CS. (1995) Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45(suppl 6): S16 - S21.
25. Friedlander RM, Gagliardini V, Rotello RJ, Yuan J. (1996) Functional role of IL-1β and IL-1b-converting enzyme-mediated apoptosis. J Exp Med 184: 717 - 724.
26. Parkinson J, Mitrovic B, Merrill JE. (1997) The role of nitric oxide in multiple sclerosis. J Mol Med 75: 174 - 186.
27. Heuschling P. (1995) Nitric oxide modulates gamma-interferon-induced class II antigen expression on rat astrocytes. J Neuroimmunol 57: 63 - 69.
28. Merrill JE, Benveniste EN. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. TINS 19: 331 - 338.
29. van Snick JV. (1990) Interlukin-6: an overview. Ann Rev Immunol 8: 253 - 278.
30. Perez L et al. (1995) B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: Dependency on local IL-6 production. Clin Exp Immunol 101: 449 - 452.
31. Maimone D, Guazzi GC, Annunziata P. (1997) IL-6 detection in multiple sclerosis brain. J Neurol Sci 146: 59 - 65.
32. Diab A, et al. (1997) High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J Neuropathol Exp Neurol 56: 641 - 650.
33. Peress NS, Perillo E, Seidman RJ. (1996) Glial transforming growth factor. (TGF)-beta isotypes in multiple sclerosis: Differential glial expression of TGF-beta1, 2 and 3 isotypes in multiple sclerosis. J Neuroimmunol 71: 115 - 123.
34. Mokhtarian F et al. (1994) Defective production of anti-inflammatory cytokine, TGF-β by T cell lines of patients with active multiple sclerosis, J Immunol 152: 6003 - 6010.
35. Link J. (1994) Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol Scand 90(suppl 158): 1 - 58.